Literature DB >> 3070381

AAEE case report #16: Botulism.

J B Pickett1.   

Abstract

Botulinal toxin causes a marked reduction in the number of quanta released by autonomic and motor nerve terminals. As a result it causes blurred vision, inability to move the eyes, weakness of other cranial nerve-innervated muscles, dyspnea progressing to apnea, and generalized weakness. Electrodiagnostic findings in severe botulism can be relatively nonspecific, with low amplitude and short duration motor unit action potentials and small M wave amplitudes. A modest increment in M wave amplitude with rapid repetitive nerve stimulation may help to localize the disorder to the neuromuscular junction. Identification of the toxin in the patient's serum is diagnostic. The treatment of botulism is mainly supportive.

Entities:  

Mesh:

Year:  1988        PMID: 3070381     DOI: 10.1002/mus.880111203

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Botulism with sensory symptoms: a second case.

Authors:  J C Martínez-Castrillo; M A Del Real; A Hernandez Gonzalez; G De Blas; J C Alvarez-Cermeño
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

2.  Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome.

Authors:  F Erbguth; D Claus; A Engelhardt; D Dressler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

Review 3.  Botulinum toxin. From poison to medicine.

Authors:  L E Davis
Journal:  West J Med       Date:  1993-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.